← Leaderboards
Angelo Michael De Marzo
Johns Hopkins University
$8,441,808
Attributed
$11,359,448
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,442,422 · 13
By mechanism
U54$8,715,760 · 6
U01$5,753,046 · 1
P30$1,261,576 · 2
R01$882,142 · 1
P50$558,143 · 2
K08$271,755 · 1
Top collaborators
- Kenneth J. Pienta7 shared
- Srinivasan Yegnasubramanian6 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- William George Nelson$34,555,726
- Kenneth J. Pienta$43,861,680
- Martin G Pomper$38,517,075
- William B Isaacs$27,729,214
- Marcia R Cruz Correa$7,817,319
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResearch PersonnelGenomicsMalignant Neoplasm Of ProstateProstateLesionTissuesIn Situ HybridizationTechnologyAutopsyDiagnosisDatabasesDesignImmunohistochemistryEpigenomicsMolecularNeoplastic CellTranscriptome SequencingDna MethylationInflammationImageResource SharingInflammatoryMouse Model
Grant awards (41)
Prostate inflammatory lesions as a proving ground for development of aggressive prostate cancer$1,516,118
U54 · FY2025 · CA · contact PI
TBEL Administrative Core$391,733
U54 · FY2025 · CA · contact PI
Elucidating and testing causal drivers of inflammation triggered prostatic early lesions$289,561
U54 · FY2025 · CA · contact PI
Biospecimen Core$283,041
P50 · FY2025 · CA · contact PI
Prostate inflammatory lesions as a proving ground for development of aggressive prostate cancer$1,440,117
U54 · FY2024 · CA · contact PI
TBEL Administrative Core$375,071
U54 · FY2024 · CA · contact PI
Elucidating and testing causal drivers of inflammation triggered prostatic early lesions$278,890
U54 · FY2024 · CA · contact PI
Biospecimen Core$275,102
P50 · FY2024 · CA · contact PI
Prostate inflammatory lesions as a proving ground for development of aggressive prostate cancer$1,485,601
U54 · FY2023 · CA · contact PI
TBEL Administrative Core$380,980
U54 · FY2023 · CA · contact PI
Elucidating and testing causal drivers of inflammation triggered prostatic early lesions$287,979
U54 · FY2023 · CA · contact PI
Admin-Core-001$82,234
U54 · FY2023 · CA · contact PI
Spatial and mechanistic assessment of the role of stromal fibroblasts in driving emergence of aggressive prostate and bladder cancer$82,234
U54 · FY2023 · CA · contact PI
Prostate inflammatory lesions as a proving ground for development of aggressive prostate cancer$1,558,904
U54 · FY2022 · CA · contact PI
Elucidating and testing causal drivers of inflammation triggered prostatic early lesions$379,776
U54 · FY2022 · CA · contact PI
TBEL Administrative Core$166,562
U54 · FY2022 · CA · contact PI
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry$648,412
U01 · FY2020 · CA
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry$1,232,006
U01 · FY2019 · CA
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry$1,122,515
U01 · FY2018 · CA
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry$802,958
U01 · FY2017 · CA
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry$327,000
U01 · FY2017 · CA
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry$810,157
U01 · FY2016 · CA
TISSUE MICROARRAY$121,816
P30 · FY2016 · CA · contact PI
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry$809,998
U01 · FY2015 · CA
TISSUE MICROARRAY$121,816
P30 · FY2015 · CA · contact PI
TISSUE MICROARRAY$116,908
P30 · FY2014 · CA · contact PI
TISSUE MICROARRAY$113,892
P30 · FY2013 · CA · contact PI
TISSUE MICROARRAY$121,816
P30 · FY2012 · CA · contact PI
TISSUE MICROARRAY$171,508
P30 · FY2010 · CA · contact PI
TISSUE MICROARRAY$173,866
P30 · FY2009 · CA · contact PI
TISSUE MICROARRAY$68,548
P30 · FY2009 · CA · contact PI
TISSUE MICROARRAY$83,802
P30 · FY2008 · CA · contact PI
TISSUE MICROARRAY$83,802
P30 · FY2007 · CA · contact PI
TISSUE MICROARRAY$83,802
P30 · FY2006 · CA · contact PI
INFLAMMATION AND ATROPHY IN PROSTATE CARCINOGENESIS$284,524
R01 · FY2003 · CA
Core--Tissue archive$0
P50 · FY2003 · CA
INFLAMMATION AND ATROPHY IN PROSTATE CARCINOGENESIS$285,713
R01 · FY2002 · CA
MOLECULAR PATHOLOGY OF STEM CELLS IN CANCER$90,585
K08 · FY2002 · CA
INFLAMMATION AND ATROPHY IN PROSTATE CARCINOGENESIS$311,905
R01 · FY2001 · CA
MOLECULAR PATHOLOGY OF STEM CELLS IN CANCER$90,585
K08 · FY2001 · CA
MOLECULAR PATHOLOGY OF STEM CELLS IN CANCER$90,585
K08 · FY2000 · CA